Search Results
Panel 2 — Incorporating Patient Reported Outcomes to Inform Dose Selection and Optimization
Harness Patient Reported Outcomes
Friends of Cancer Research Annual Meeting Day 2
Friends of Cancer Research Annual Meeting 2023
Friends of Cancer Research Annual Meeting 2022
Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development
The Promise of PROs (Patient-Reported Outcomes)
SBS Day 2 - Session IV: Clinical Trial Design Considerations
Patient-Reported Outcomes for Toxicity and Symptom Monitoring in Oncology
January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting
PFDD Workshop to Discuss Methodologic & Other Challenges Related to Patient Experience Data – Part 2
How to Define & Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing
